KPIs & Operating Metrics(New)
Growth Metrics

Encompass Health (EHC) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to 0.85%.

  • Encompass Health's EBITDA Margin fell 100400.0% to 0.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.22%, marking a year-over-year decrease of 33500.0%. This contributed to the annual value of 11.1% for FY2024, which is 14600.0% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's EBITDA Margin is 0.85%, which was down 100400.0% from 3.11% recorded in Q2 2025.
  • Over the past 5 years, Encompass Health's EBITDA Margin peaked at 14.18% during Q2 2021, and registered a low of 0.85% during Q3 2025.
  • Over the past 5 years, Encompass Health's median EBITDA Margin value was 10.39% (recorded in 2022), while the average stood at 9.77%.
  • Per our database at Business Quant, Encompass Health's EBITDA Margin surged by 110600bps in 2021 and then plummeted by -100400bps in 2025.
  • Over the past 5 years, Encompass Health's EBITDA Margin (Quarter) stood at 11.1% in 2021, then decreased by -7bps to 10.33% in 2022, then dropped by -8bps to 9.55% in 2023, then increased by 22bps to 11.69% in 2024, then tumbled by -93bps to 0.85% in 2025.
  • Its last three reported values are 0.85% in Q3 2025, 3.11% for Q2 2025, and 13.5% during Q1 2025.